Extramural Funding Opportunities

The CAIRIBU U24 Interactions Core curates and maintains a collection of funding opportunities for CAIRIBU-affiliated investigators. This includes grants from the National Institutes of Health, institution-specific funding aimed at enhancing stakeholder engagement in research, and various funding sources that support non-malignant urologic research.

NIDDK Funding Annoucements

Other NIH Funding Annoucements

Other Funding Announcements

  • Science Diversity Leadership Award

    The Science Diversity Leadership Award (SDLA) will support Principal Investigators who are outstanding early to mid-career biomedical researchers who have a record of promoting diversity, equity, and inclusion (DEI) in their scientific communities. [Posted 10/03/2024. LOI is due 12/01/2024  5:00pm PT]

  • Innovative Science Accelerator Program (ISAC)

    The ISAC Award provides seed funding for exceptionally innovative, disruptive (high-risk/high-reward) research relevant to Kidney-Urologic-Hematologic communities that has the potential to lead to groundbreaking or paradigm-shifting results that will change the field. [Next deadline 3/12/25]

  • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 – Clinical Trial Not Allowed).

    This notice of funding opportunity (NOFO) aims to encourage research grant applications for initial translational efforts that will enable a drug discovery program for novel, non-opioid, and non-addictive treatments for pain. [Posted 9/18/24. Expires 1/16/27]

  • More Other Funding posts

Institution-Specific CTSA Stakeholder Engagement Funding Announcements

NIH Data Book – The NIH Data Book (NDB) provides basic summary statistics on extramural grants and contract awards, grant applications, the organizations that NIH supports, the trainees and fellows supported through NIH programs, and the national biomedical workforce.